A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers
Status unconfirmed
Conditions studied: Head and Neck Cancer
In brief
The project is designed to test new biomarkers that are more sensitive than the current standard in detecting injury to the proximal kidney tubule and will establish better criteria for when kidney safety concerns may halt further testing of a drug in humans.
Key facts
- Study ID
- NCT01936376
- Run by
- Foundation for the National Institutes of Health
- People needed
- 150
- Starts
- 2012-09-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2015-01-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States (enrolling)
- University of Texas MD Anderson — Houston, Texas, United States (enrolling)
- Harvard Medical School - Brigham and Women's Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.